Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Hu Hai, explained in plain language.
This study is testing whether combining two drugs, inavolisib and eribulin, can help control advanced triple-negative breast cancer that has a specific genetic change (PIK3CA mutation) and has worsened after at least one prior treatment. It will enroll about 26 patients to see ho…
Phase: PHASE2 • Sponsor: Hu Hai • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC